Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Acorda Therapeutics (ACOR)

Acorda Therapeutics (ACOR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,863
  • Shares Outstanding, K 48,030
  • Annual Sales, $ 471,430 K
  • Annual Income, $ 33,680 K
  • 60-Month Beta 1.26
  • Price/Sales 0.47
  • Price/Cash Flow 1.01
  • Price/Book 0.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.70
  • Number of Estimates 4
  • High Estimate -0.56
  • Low Estimate -1.07
  • Prior Year 0.41
  • Growth Rate Est. (year over year) -270.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.82 +15.70%
on 01/15/20
2.78 -24.46%
on 12/26/19
+0.18 (+9.37%)
since 12/24/19
3-Month
1.49 +40.94%
on 11/21/19
2.78 -24.46%
on 12/26/19
+0.10 (+5.00%)
since 10/24/19
52-Week
1.49 +40.94%
on 11/21/19
17.41 -87.94%
on 01/31/19
-13.46 (-86.50%)
since 01/24/19

Most Recent Stories

More News
Implied Volatility Surging for Acorda (ACOR) Stock Options

Investors need to pay close attention to Acorda (ACOR) stock based on the movements in the options market lately.

ACOR : 2.10 (-11.39%)
Acorda Provides 2019 Highlights and 2020 Guidance at J.P. Morgan Healthcare Conference

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided 2019 highlights and 2020 guidance and priorities at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco.

JPM : 133.15 (-2.48%)
ACOR : 2.10 (-11.39%)
Acorda to Present at the 38th Annual J.P. Morgan Healthcare Conference

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., Acorda's President and CEO, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January...

JPM : 133.15 (-2.48%)
ACOR : 2.10 (-11.39%)
Acorda Therapeutics (ACOR) in Focus: Stock Moves 5.7% Higher

Acorda Therapeutics (ACOR) shares rose nearly 6% in the last trading session, amid huge volumes.

ACOR : 2.10 (-11.39%)
AMRN : 20.22 (-2.60%)
Watch for Acorda Therapeut to Potentially Pullback After Gaining 27.60% Yesterday

Acorda Therapeut (NASDAQ:ACOR) traded in a range yesterday that spanned from a low of $1.93 to a high of $2.62. Yesterday, the shares gained 27.6%, which took the trading range above the 3-day high of...

ACOR : 2.10 (-11.39%)
Acorda Therapeutics Completes Exchange of $276 Million of its 1.75% Convertible Senior Notes due June 2021; New Convertible Secured Notes Mature December 2024

Acorda Therapeutics, Inc. (Nasdaq: ACOR) ("Acorda" or the "Company") today announced it has successfully completed its previously announced private exchange of $276 million aggregate principal amount of...

ACOR : 2.10 (-11.39%)
Acorda Therapeutics Announces Private Exchange of $276 Million of Its 1.75% Convertible Senior Notes Due 2021

Acorda Therapeutics, Inc. (Nasdaq: ACOR) (the "Company") today announced that it has entered into agreements with a limited number of institutional investors who are holders of the Company's 1.75% Convertible...

ACOR : 2.10 (-11.39%)
Watch for Acorda Therapeut to Potentially Rebound After Falling 1.18% Yesterday

Acorda Therapeut (NASDAQ:ACOR) traded in a range yesterday that spanned from a low of $1.64 to a high of $1.71. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $1.68...

ACOR : 2.10 (-11.39%)
Acorda Therapeut Set to Possibly Pullback After Yesterday's Rally of 17.08%

Acorda Therapeut (NASDAQ:ACOR) traded in a range yesterday that spanned from a low of $1.85 to a high of $2.12. Yesterday, the shares gained 17.1%, which took the trading range above the 3-day high of...

ACOR : 2.10 (-11.39%)
Acorda (ACOR) Down 13.5% Since Last Earnings Report: Can It Rebound?

Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ACOR : 2.10 (-11.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ACOR with:

Business Summary

Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis....

See More

Key Turning Points

2nd Resistance Point 2.61
1st Resistance Point 2.35
Last Price 2.10
1st Support Level 1.97
2nd Support Level 1.85

See More

52-Week High 17.41
Fibonacci 61.8% 11.33
Fibonacci 50% 9.45
Fibonacci 38.2% 7.57
Last Price 2.10
52-Week Low 1.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar